7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2014-12-31 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2011-12-31 2011-09-30 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-06-30 2009-03-31 2008-09-30 2008-06-30 2008-03-31 2007-09-30 2007-06-30 2007-03-31 2006-09-30 2006-06-30 2006-03-31 2005-09-30 2005-06-30 2005-03-31 2004-09-30 2004-06-30 2004-03-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 
      
    		                                                                          
      cash flows from operating activities:
    		                                                                          
      net income
    		379,105,000 362,612,000 321,628,000 337,047,000 265,910,000 294,330,000 265,822,000 219,622,000 168,008,000 169,302,000 162,375,000 170,369,000 176,811,000 158,781,000 151,021,000 233,911,000 219,375,000 325,276,000 209,070,000 307,734,000 244,092,000 256,504,000 144,460,000 248,010,000 100,870,000 241,265,000 237,398,000 163,622,000 174,881,000 230,711,000 228,669,000 225,035,000 145,362,000 190,388,000 210,527,000 178,738,000 157,265,000 195,449,000 215,719,000 191,317,000 163,654,000 190,492,000 151,852,000 133,186,000 123,099,000 167,803,000 129,935,000 108,007,000 94,842,000 50,816,000 65,802,000 76,415,000 82,762,000   36,997,000 54,240,000 61,663,000 28,854,000 52,071,000 49,508,000 113,945,000 60,259,000 51,084,000 8,319,000 158,843,000 61,409,000 132,318,000 94,473,000 46,183 49,061 50,950 52,790 175,229,529 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                                          
      depreciation & amortization
    		155,060,000 152,004,000 148,345,000 146,781,000 149,567,000 147,480,000 141,003,000 145,481,000 137,195,000 143,744,000 141,621,000 148,353,000 145,874,000 143,850,000 143,784,000 133,363,000 134,462,000 133,985,000 131,403,000 133,930,000 125,961,000 126,208,000 124,394,000 127,656,000 121,528,000 121,168,000 120,040,000 118,074,000 112,286,000 109,582,000 113,134,000 113,756,000 110,217,000 113,112,000 110,798,000 107,436,000 103,712,000 101,411,000 104,049,000 102,921,000 99,442,000 98,118,000 93,359,000 88,708,000 86,971,000 81,754,000 79,923,000 75,653,000 75,259,000 60,931,000 55,530,000 54,025,000 53,511,000 51,084,000 51,135,000 49,332,000 48,009,000 47,370,000 46,529,000 45,406,000 43,482,000 40,961,000 40,369,000 39,030,000 38,705,000 40,252,000 45,506,000 124,407,000 81,399,000 40,706 35,799 35,513 34,537  
      gain on sales of assets and businesses
    		0                                                                          
      costs related to extinguishment of debt
    		   0            0    0                        0                               
      stock-based compensation expense
    		24,879,000 24,112,000 21,595,000 26,622,000 26,565,000 26,532,000 19,630,000 22,018,000 22,640,000 22,098,000 20,964,000 22,637,000 21,101,000 22,585,000 19,055,000 18,138,000 18,517,000 19,009,000 18,022,000 15,909,000 15,974,000 15,907,000 18,047,000 17,264,000 17,491,000 17,085,000 17,591,000 15,936,000 15,929,000 15,016,000 19,700,000 13,900,000 13,785,000 13,705,000 15,348,000 11,751,000 11,665,000 11,489,000 13,204,000 9,826,000 9,671,000 8,379,000 7,152,000  6,493,000 6,468,000 7,111,000  4,769,000  4,351,000 4,262,000 4,065,000                      
      changes in assets & liabilities, net of effects from acquisitions and dispositions:
    		                                                                          
      accounts receivable
    		-201,574,000 125,738,000 -218,374,000 55,652,000 -54,471,000 140,620,000 -74,446,000 10,664,000 -111,030,000 -66,355,000 -15,723,000 -103,196,000 -65,413,000 -74,656,000 -15,073,000 20,206,000 6,824,000 -92,754,000 56,851,000 -191,336,000 -85,859,000 61,531,000 69,763,000 -4,724,000 63,997,000 290,000 -101,619,000 31,890,000 -10,074,000 8,471,000 -72,526,000 -34,809,000 9,149,000 6,303,000 -5,362,000 -81,045,000 38,893,000 34,233,000 -79,962,000 15,063,000 34,136,000 -7,515,000 -95,633,000 49,553,000 -17,037,000 -365,000 -81,859,000 -31,138,000 -26,039,000 29,477,000 9,772,000 29,976,000 -46,499,000 49,286,000 -44,894,000 65,393,000 -11,276,000 -63,587,000 18,932,000 21,016,000 -57,307,000 -38,514,000 1,456,000 -48,074,000 38,043,000 19,602,000 -65,960,000 -43,065,000 -39,323,000 -71,645 -11,852 40,224 -20,762 -34,955,583 
      accrued interest
    		11,584,000 -15,618,000 11,086,000 14,576,000 -5,072,000 -143,000 3,453,000 1,133,000 167,000 555,000 -662,000 1,306,000 -800,000 1,149,000 180,000 1,236,000 5,173,000 -11,592,000 10,133,000 498,000 -8,335,000 2,221,000 -4,412,000 3,171,000 -3,910,000 3,635,000 -2,687,000 1,330,000 -6,007,000 6,408,000 -6,209,000 6,452,000 -5,958,000 6,334,000 -6,123,000 6,463,000 -5,855,000 8,470,000 688,000 -396,000 1,223,000 -2,147,000 11,063,000 -11,573,000 -2,823,000 1,702,000 11,497,000 -16,720,000 15,452,000 -29,000 10,194,000 -10,114,000 8,357,000 -10,385,000 10,491,000 10,479,000 -8,188,000 8,999,000 -205,000 -274,000 9,534,000 8,007,000 -3,825,000 3,337,000 3,716,000 -3,413,000 4,147,000 4,132,000 28,000 4,510 1,988 -2,065 2,329 636,949 
      accrued and deferred income taxes
    		16,626,000 -144,554,000 88,641,000 23,600,000 -37,919,000 -45,223,000 72,193,000 -10,210,000 -545,000 -79,271,000 46,576,000 -24,610,000 29,360,000 -81,808,000 47,548,000 -1,303,000 -25,958,000 -80,538,000 53,769,000 11,688,000 -118,802,000 71,507,000 45,200,000 28,520,000 -36,868,000 -69,137,000 52,291,000 -887,000 -10,625,000 -104,214,000 61,674,000 13,772,000 -14,648,000 -107,798,000 102,269,000 9,881,000 -5,810,000 -73,134,000 91,131,000 -21,826,000 -23,438,000 52,312,000 65,321,000 13,943,000 2,553,000 -50,525,000 68,890,000 -17,157,000 47,529,000 2,788,000 -6,602,000 -33,434,000 37,380,000 -20,128,000 28,062,000 -6,706,000 -28,013,000 31,301,000 994,000 -34,741,000 27,373,000 -20,450,000 30,077,000 27,118,000   32,084,000 27,395,000 16,004,000 25,667 26,537 -29,561 31,288 7,346,710 
      other working capital accounts
    		-4,909,000 68,148,000 -42,824,000 60,568,000 -38,357,000 72,977,000 -33,291,000 32,741,000 -85,278,000 139,821,000 -119,605,000 27,211,000 -75,092,000 -162,119,000 63,308,000 -6,090,000 49,056,000 -79,103,000 82,663,000 38,601,000 59,583,000 -47,568,000 73,929,000 -50,598,000 60,180,000 -77,796,000 107,878,000 -64,461,000 80,180,000 -50,055,000 59,032,000 -38,894,000 117,444,000 -160,592,000 66,877,000 -50,498,000 1,672,000 24,343,000 98,972,000 -71,538,000 -43,119,000 14,299,000 -34,999,000 15,921,000 -22,108,000 72,206,000 -39,785,000 45,960,000 -25,925,000 -53,134,000 42,450,000 -13,364,000 -2,389,000 -8,080,000 6,581,000 17,610,000 -9,446,000 27,777,000 47,683,000 -13,690,000 13,565,000 14,859,000 -37,337,000 30,635,000 -4,027,000 22,288,000 25,197,000 26,252,000 42,350,000 16,310 425 22,554 -35,087 23,660,600 
      other assets and deferred charges
    		-7,225,000 -21,915,000 -489,000 -6,542,000 -2,591,000 17,277,000 -20,307,000 -468,000 16,239,000 8,019,000 24,727,000 -2,301,000 -8,059,000 4,236,000 26,042,000 -5,299,000 -5,275,000 -28,746,000 -17,000 -5,826,000 -3,824,000 -5,989,000 11,084,000 -42,442,000 16,570,000 2,438,000 -3,771,000 5,704,000 -22,989,000 -8,706,000 -5,438,000 -6,809,000 -1,871,000 -12,172,000 -7,755,000 -14,220,000 -3,302,000 -2,346,000 -5,803,000 2,000 2,555,000 -2,201,000 9,982,000 -4,441,000 4,356,000 2,407,000 6,662,000 16,945,000 8,690,000 27,281,000 -8,872,000 -2,639,000 -4,231,000 5,746,000 -1,902,000 496,000 14,470,000 1,351,000 3,820,000 -972,000 -2,811,000 7,799,000 -1,895,000 1,039,000 -806,000 -11,897,000 15,451,000 -3,957,000 -2,259,000 7,310 5,642 2,169 9,783 -5,110,153 
      other
    		2,971,000 12,332,000 3,811,000 -3,921,000 11,455,000 5,380,000 8,897,000 25,416,000 -1,754,000 8,441,000 7,030,000 14,682,000 -7,595,000 -11,743,000 -4,020,000 -91,682,000 4,555,000 2,429,000 2,623,000 -6,264,000 123,090,000 -4,621,000 -3,038,000 64,168,000 -6,778,000 -11,389,000 -38,298,000 41,607,000 4,132,000 56,518,000 -37,642,000 12,100,000 -31,253,000 -23,182,000 -229,000 23,099,000 5,990,000 31,139,000 20,911,000 10,155,000 10,977,000 9,449,000 -3,833,000 17,693,000 1,709,000 2,479,000 1,604,000 -5,533,000 678,000 5,368,000 -43,000 -349,000 -4,164,000 4,400,000 -1,073,000 6,937,000 7,124,000 -1,714,000 6,163,000 2,801,000 -4,041,000 3,529,000 3,177,000 4,707,000 3,076,000 384,000 3,733,000 7,086,000 1,386,000 5,035 -5,078 -4,181 -1,097 -6,193,212 
      accrued insurance expense, net of commercial premiums paid
    		82,358,000 47,362,000 47,334,000 79,290,000 72,882,000 51,110,000 51,112,000 42,048,000 46,257,000 52,612,000 42,545,000 39,815,000 37,338,000 55,885,000 41,685,000 45,513,000 36,623,000 68,612,000 35,467,000 45,652,000 32,555,000 31,457,000 49,559,000 29,427,000 24,426,000 27,421,000 24,398,000 23,477,000 23,131,000 23,130,000 23,125,000 21,781,000 21,911,000 36,896,000 22,007,000 18,589,000 21,818,000 21,615,000 22,616,000 15,180,000 25,204,000 1,547,000 21,302,000 -2,415,000 21,184,000 -45,552,000 22,962,000 12,426,000 23,706,000 -13,031,000 17,279,000 -3,469,000 18,960,000 -6,691,000 20,014,000 19,384,000 19,367,000 19,376,000 21,880,000 324,000 23,071,000 20,205,000 18,644,000 22,529,000 20,414,000 21,083,000 21,862,000 57,637,000 39,307,000 19,024 15,328 15,241 15,399 58,274,059 
      payments made in settlement of self-insurance claims, net of commercial insurance reimbursements
    		-78,197,000                                                                          
      net cash from operating activities
    		380,678,000 548,978,000 360,048,000 658,437,000 332,977,000 679,281,000 396,406,000 452,431,000 161,665,000 362,948,000 290,753,000 297,304,000 220,672,000 32,614,000 445,433,000 322,020,000 442,227,000 47,653,000 71,795,000 142,012,000 766,788,000 949,307,000 502,062,000 389,159,000 425,224,000 233,185,000 390,901,000 365,405,000 346,227,000 265,210,000 364,051,000 304,316,000 344,673,000 50,584,000 483,008,000 188,369,000 298,923,000 336,955,000 464,227,000 224,399,000 264,896,000 346,322,000 194,639,000 292,509,000 185,730,000 218,239,000 187,763,000 155,749,000 206,726,000 101,745,000 180,229,000 83,653,000 135,717,000 144,578,000 152,002,000 197,477,000 66,790,000 131,676,000 163,805,000 60,000,000 98,976,000 60,948,000 78,732,000 110,340,000 126,005,000 95,826,000 134,612,000 313,514,000 224,675,000 95,126 103,224 129,412 80,766 331,013,819 
      capex
    		-2,237,000 32,691,000 116,196,000 30,776,000 -20,927,000 48,135,000 60,125,000 -41,513,000 7,951,000 39,120,000 61,341,000 -25,200,000 -15,156,000 21,690,000 90,730,000 93,806,000 -22,551,000 35,855,000 60,124,000 -1,548,000 -3,629,000 21,096,000 58,935,000 -20,038,000 11,629,000 -64,000 71,987,000 -11,258,000 -2,810,000 7,034,000 84,708,000 17,538,000 1,869,000 6,662,000 56,427,000 20,383,000 2,572,000 -4,627,000 47,374,000 11,858,000 2,740,000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
      free cash flows
    		378,441,000 581,669,000 476,244,000 689,213,000 312,050,000 727,416,000 456,531,000 410,918,000 169,616,000 402,068,000 352,094,000 272,104,000 205,516,000 54,304,000 536,163,000 415,826,000 419,676,000 83,508,000 131,919,000 140,464,000 763,159,000 970,403,000 560,997,000 369,121,000 436,853,000 233,121,000 462,888,000 354,147,000 343,417,000 272,244,000 448,759,000 321,854,000 346,542,000 57,246,000 539,435,000 208,752,000 301,495,000 332,328,000 511,601,000 236,257,000 267,636,000 346,322,000 194,639,000 292,509,000 185,730,000 218,239,000 187,763,000 155,749,000 206,726,000 101,745,000 180,229,000 83,653,000 135,717,000 144,578,000 152,002,000 197,477,000 66,790,000 131,676,000 163,805,000 60,000,000 98,976,000 60,948,000 78,732,000 110,340,000 126,005,000 95,826,000 134,612,000 313,514,000 224,675,000 95,126 103,224 129,412 80,766 331,013,819 
      cash flows from investing activities:
    		                                                                          
      property and equipment additions
    		-228,892,000 -266,014,000 -239,026,000 -245,945,000 -247,932,000 -241,394,000 -208,539,000 -206,390,000 -200,001,000 -167,912,000 -168,752,000 -164,446,000 -161,593,000 -207,960,000 -200,002,000 -189,634,000 -183,814,000                                                      -68,811 -58,077 -40,342 -200,773,316 
      proceeds received from sales of assets and businesses
    		0   8,344,000 24,791,000 0 5,428,000 499,000 0 14,429,000 9,259,000 0 1,769,000 0 10,232,000 4,282,000 0   317,000 1,411,000   1,953,000 7,497,000 0 0 0 0 12,663,000 839,000                          0 2,235,000       0 252,547,000 124,589,000 81,352,000 68,777,000 425     
      acquisition of businesses and property
    		-39,458,000 0 -8,314,000 -18,998,000    0 0   -1,643,000 -6,181,000   -66,024,000     -51,041,000                                                      
      outflows from foreign exchange contracts that hedge our net u.k. investment
    		                                                                          
      costs incurred for purchase and development of enterprise resource planning application
    		                                                                          
      decrease in capital reserves of commercial insurance subsidiary
    		  -264,000 79,000 1,000 41,000 155,000  0 0 0  0 0 100,000  0 0 100,000      0 0 0                                                
      net cash from investing activities
    		-269,413,000 -305,939,000 -271,299,000 -207,993,000 -265,637,000 -242,842,000 -194,637,000 -238,847,000 -176,419,000 -169,698,000 -178,311,000 -248,390,000 -73,326,000 -156,620,000 -168,960,000 -254,756,000 -176,009,000 -221,374,000 -262,327,000 -227,859,000 -277,888,000 -161,796,000 -135,019,000 -275,757,000 -116,254,000 -128,889,000 -167,510,000 -158,238,000 -239,433,000 -189,449,000 -226,278,000 -156,695,000 -163,194,000 -129,884,000 -174,626,000 -654,833,000 -257,144,000 -128,483,000 -146,757,000 -462,948,000 -244,857,000 -125,054,000 -90,742,000 -97,152,000 -109,654,000 -70,978,000 -105,674,000 -77,610,000 -82,580,000 -1,780,821,000 -296,622,000 -56,958,000 -59,682,000 -114,035,000 -78,219,000 -68,427,000 -74,867,000 -79,516,000 -100,743,000 -93,055,000 -182,221,000 -20,168,000 -46,985,000 -66,938,000 -86,906,000 201,620,000 61,444,000 -243,293,000 -191,632,000 -107,676 -57,213 -56,877 -82,846 -195,406,066 
      cash flows from financing activities:
    		                                                                          
      repayments of long-term debt
    		-9,243,000 -9,435,000 -9,113,000 -168,486,000 -2,088,840,000 -318,770,000 -63,905,000 -31,471,000 39,548,000 -77,068,000 -16,489,000 104,748,000 32,739,000 -214,888,000 -11,966,000 -10,980,000                                                           
      additional borrowings
    		114,385,000 -57,853,000 152,454,000 0 2,198,210,000 0 12,038,000 20,100,000 165,000,000 -11,300,000 11,300,000 0 5,321,000 582,600,000 117,400,000 342,600,000 2,905,796,000   -1,598,000 797,744,000 0 5,453,000 24,120,000 -162,100,000 168,500,000 8,700,000 708,847,000 51,900,000 10,000,000 20,500,000 -2,024,000 21,524,000 0 21,600,000    14,400,000 218,100,000 11,100,000 -139,800,000 11,900,000 14,261,000 -9,500,000 1,500,000 9,500,000 62,100,000 0 3,016,146,000 250,000,000       33,180,000 53,729,000 31,607,000 84,664,000 0   0 -291,000 8,114,000 24,107,000     38,738  
      financing costs
    		   -2,574,000    0 -15,000 -1,000 -292,000 -623,000 -154,000   -803,000    -2,044,000    0 0   -13,013,000 -20,000   -42,000 -34,000 0 0 -119,000 -1,596,000 -10,690,000 -44,000 -515,000  -1,563,000  -231,000    -49,000 -25,000 -96,799,000            -395,000             
      repurchase of common shares
    		-237,399,000 -155,157,000 -223,385,000 -250,166,000 -182,601,000 -95,903,000 -142,084,000 -162,024,000 -175,583,000 -124,717,000 -85,039,000 -109,534,000 -158,202,000 -199,677,000 -365,505,000 -450,210,000 -402,585,000 -360,616,000 -7,464,000 -6,621,000 -44,000 -27,962,000 -172,092,000 -182,528,000 -93,327,000 -350,864,000 -143,785,000 -136,169,000 -126,472,000 -125,343,000 -9,441,000 -121,531,000 -95,407,000 -118,296,000 -29,167,000 -56,203,000 -58,038,000 -68,097,000 -171,042,000 -79,920,000 -61,705,000 -37,457,000 -13,993,000 -5,015,000 -813,000 -7,346,000 -14,027,000 -15,950,000 -38,369,000 -7,565,000 -260,000 -1,546,000 -2,157,000 -712,000 -14,725,000 -14,620,000 -17,000 -89,799,000 -11,045,000 -53,000 -3,288,000 -149,335,000 -69,442,000 -1,566,000 -66,911,000 -156,271,000 -1,255,000 -5,924,000 -350,000 -350 -733 -30,822 -22,517 -76,606,497 
      dividends paid
    		-12,468,000 -12,900,000 -13,534,000 -13,044,000 -13,296,000 -13,405,000 -13,601,000 -13,516,000 -13,701,000 -14,049,000 -14,214,000 -14,257,000 -14,551,000 -14,766,000 -14,875,000 -15,612,000 -16,440,000 -16,826,000 -17,018,000 0 0 0 -17,344,000 -17,447,000 -17,603,000 -8,872,000 -9,081,000 -9,256,000 -9,282,000 -9,382,000 -9,422,000 -9,435,000 -9,496,000 -9,618,000 -9,662,000 -9,678,000 -9,713,000 -9,727,000 -9,757,000 -9,836,000 -9,892,000 -9,871,000 -4,933,000 -4,915,000 -4,911,000 -4,925,000 -4,870,000 -4,828,000 -4,875,000 -4,867,000 -4,862,000 -4,859,000 -4,834,000 -3,928,000 -3,962,000 -4,051,000 -4,024,000 -4,072,000 -4,296,000 -4,311,000 -4,310,000 -4,470,000 -4,334,000 -4,286,000 -4,467,000 -4,470,000 -4,645,000 -13,984,000 -9,303,000 -4,650     
      issuance of common stock
    		3,982,000 4,479,000 3,658,000 4,206,000 3,637,000 3,986,000 3,241,000 3,813,000 3,243,000 3,610,000 2,988,000 3,669,000 3,738,000 3,158,000 3,503,000 3,264,000 3,666,000 3,085,000 3,357,000 3,030,000 3,436,000 2,850,000 3,002,000 2,558,000 2,977,000 2,545,000 2,726,000 2,459,000 2,778,000 2,414,000 2,545,000 2,617,000 2,710,000 2,387,000 2,540,000 3,124,000 2,017,000 2,031,000 2,331,000 2,411,000 1,991,000 1,956,000 1,445,000 1,612,000 1,361,000 1,503,000 1,232,000 1,183,000 1,188,000 -1,610,000 1,371,000 2,206,000 1,627,000 683,000 667,000 600,000 58,000 1,093,000 -403,000 1,329,000 115,000 1,567,000 1,054,000 1,584,000 856,000 10,672,000 771,000 2,340,000 1,795,000 1,431    2,945,214 
      profit distributions to noncontrolling interests
    		-788,000 -3,709,000 -5,912,000 -717,000 -702,000 -609,000 -4,480,000 -1,572,000 -523,000 -590,000 -4,145,000 35,000 -103,000 -34,000 -5,289,000 -1,336,000 -127,000 -1,092,000 -4,525,000 -4,630,000 -6,290,000 -3,150,000 -5,735,000 -3,972,000 -237,000 -1,336,000 -10,314,000 -6,352,000 -329,000 -3,697,000 -4,217,000 -8,789,000 -4,494,000 -7,312,000 -4,118,000 -8,530,000 -1,438,000 -56,208,000 -3,407,000 -26,255,000 -12,670,000 -8,606,000 -1,989,000 -10,081,000 -24,514,000 -16,660,000 -10,074,000 -4,535,000 -10,761,000 -8,898,000 -11,222,000 -7,713,000 -4,623,000                      
      purchase (sale) of ownership interests by (from) minority member
    		7,392,000 6,924,000 4,412,000                                                                        
      net cash from financing activities
    		-134,521,000 -227,651,000 -91,420,000 -426,760,000 -89,650,000 -419,520,000 -208,947,000 -182,316,000 17,970,000 -223,708,000 -105,891,000 -15,373,000 -178,994,000 154,006,000 -278,039,000 -132,930,000 -274,147,000 -391,996,000 -269,877,000 217,667,000 71,784,000 -302,496,000 -371,814,000 -164,790,000 -309,848,000 -104,104,000 -266,294,000 -184,011,000 -98,924,000 -68,556,000 -140,711,000 -138,784,000 -183,048,000 82,119,000 -279,440,000 437,994,000 -35,467,000 -205,287,000 -323,188,000 261,267,000 -22,091,000 -228,257,000 -104,874,000 -190,241,000 -76,512,000 -152,098,000 -88,165,000 -76,057,000 -119,815,000 1,698,921,000 113,685,000 -21,223,000 -78,350,000 -29,343,000 -69,820,000 -127,456,000 5,372,000 -59,598,000 -62,151,000   -150,313,000 84,392,000 -43,154,000 -71,690,000 -236,887,000 -174,993,000 -70,530,000 -31,571,000 16,068 -44,454 -78,247 16,746 -140,698,699 
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		-1,541,000 2,286,000 1,645,000  3,088,000 100,000 -492,000  -1,884,000 727,000 1,650,000  -4,882,000 -3,225,000 -2,232,000  -1,342,000 237,000 423,000  933,000 34,000 -1,673,000  -986,000 -1,067,000 794,000  -604,000 -2,995,000 1,857,000                                            
      decrease in cash, cash equivalents and restricted cash
    		  -1,026,000            -3,798,000    -459,986,000    -6,444,000    -42,109,000                                                
      cash, cash equivalents and restricted cash, beginning of period
    		0 0 224,752,000 0 0 0 214,470,000 0 0 0 200,837,000 0 0 0 178,934,000 0 0 0 1,279,154,000 0 0 0 105,667,000 0 0 0 199,685,000 0 0 0 167,297,000                                            
      cash, cash equivalents and restricted cash, end of period
    		-24,797,000 17,674,000 223,726,000 20,155,000 -19,222,000 17,019,000 206,800,000 33,831,000 1,332,000 -29,731,000 209,038,000 35,456,000 -36,530,000 26,775,000 175,136,000 -65,483,000 -9,271,000 -565,480,000 819,168,000 133,265,000 561,617,000 485,049,000 99,223,000 -49,170,000 -1,864,000 -875,000 157,576,000 21,993,000 7,266,000 4,210,000 166,216,000                                            
      supplemental disclosures of cash flow information:
    		                                                                          
      interest paid
    		25,602,000 49,730,000 27,718,000 23,896,000 48,476,000 47,786,000 48,116,000 51,199,000 51,950,000 47,018,000 50,279,000 41,144,000 35,196,000 23,408,000 20,388,000 16,888,000 15,078,000 32,220,000 11,421,000 19,019,000 31,777,000 22,319,000 39,483,000 34,707,000 44,076,000 37,573,000 41,050,000 36,131,000 43,272,000 29,351,000 41,539,000 28,091,000 40,677,000 27,361,000 39,404,000  29,325,000 26,425,000 27,133,000    18,893,000 42,829,000 34,363,000 31,085,000 22,982,000 55,616,000 18,499,000 43,316,000 3,801,000 24,301,000 5,482,000 24,757,000 3,966,000 4,863,000 22,928,000 6,407,000 15,775,000 15,034,000 5,182,000 54,000 16,404,000 1,615,000 -2,771,000 10,975,000 4,422,000 18,608,000 15,796,000 3,187 3,396 8,936 4,367 23,189,067 
      income taxes paid, net of refunds
    		104,182,000 246,148,000 5,638,000 88,455,000 105,476,000 128,828,000 2,671,000 66,707,000 57,349,000 131,480,000 2,360,000 68,668,000 36,643,000 141,025,000 4,423,000 76,602,000 96,397,000 181,325,000 8,654,000 77,787,000 194,066,000 7,611,000 6,783,000 39,324,000 75,894,000 140,317,000 5,087,000 46,351,000 65,356,000 179,381,000 2,749,000 64,970,000 89,671,000 210,961,000 5,253,000 85,437,000 93,227,000 156,854,000 9,093,000 106,534,000 107,487,000 46,464,000 6,764,000 41,606,000 65,737,000 147,645,000 4,908,000 73,761,000 5,736,000 38,567,000 33,578,000 73,211,000 6,732,000 77,158,000 13,784,000 27,638,000 62,627,000 7,642,000 12,484,000 67,710,000 3,700,000 85,853,000 5,961,000 3,598,000 1,703,000 53,923,000 4,272,000 51,370,000 40,494,000 1,498 3,754 56,341 656 94,337,274 
      noncash purchases of property and equipment
    		-2,237,000 32,691,000 116,196,000 30,776,000 -20,927,000 48,135,000 60,125,000 -41,513,000 7,951,000 39,120,000 61,341,000 -25,200,000 -15,156,000 21,690,000 90,730,000 93,806,000 -22,551,000 35,855,000 60,124,000 -1,548,000 -3,629,000 21,096,000 58,935,000 -20,038,000 11,629,000 -64,000 71,987,000 -11,258,000 -2,810,000 7,034,000 84,708,000 17,538,000 1,869,000 6,662,000 56,427,000 20,383,000 2,572,000 -4,627,000 47,374,000 11,858,000 2,740,000                                  
      (outflows) inflows from foreign exchange contracts that hedge our net u.k. investment
    		 -42,707,000 -23,695,000     -32,972,000 23,582,000 -12,487,000 -18,818,000                                                                
      increase in capital reserves of commercial insurance subsidiary
    		                               -4,100,000 0 0 -3,000,000                                        
      increase in cash, cash equivalents and restricted cash
    		     17,019,000 -7,670,000 33,831,000 1,332,000 -29,731,000 8,201,000     -65,483,000 -9,271,000    561,617,000    -1,864,000    7,266,000 4,210,000 -1,081,000                                            
      payments made in settlement of self-insurance claims
    		  -20,705,000 -70,440,000 -56,751,000 -31,059,000 -33,935,000 -37,228,000 -29,257,000 -32,668,000 -18,936,000 -53,982,000 -29,935,000 -28,635,000 -29,431,000 -31,433,000 -17,574,000 -23,754,000 -18,741,000 -28,695,000 -20,356,000 -37,110,000 -26,924,000 -29,735,000 -23,931,000 -21,795,000 -22,320,000 -22,924,000 -14,617,000 -19,841,000 -18,765,000 -21,968,000 -19,465,000 -12,410,000 -25,349,000 -21,825,000 -27,125,000 -15,714,000 -17,298,000 -23,727,000 -14,372,000 -16,411,000 -20,793,000 -15,636,000 -17,971,000 -19,953,000 -17,085,000 -36,869,000 -12,399,000 -12,843,000 -9,632,000 -17,511,000 -10,187,000 -14,154,000 -15,669,000 -12,363,000 -11,882,000 -13,766,000 -10,626,000 -10,229,000 -12,170,000 -8,205,000 -10,375,000 -12,690,000  -7,871,000 -11,548,000 -37,986,000 -24,091,000 -6,544 -7,008 -7,970 -15,148 -31,110,464 
      (gain) loss on sales of assets and businesses
    		                                                                          
      benefit from asset impairment
    		               7,196,000 0       0                                         19,561,000 0 3,105,000        
      deferred grant revenue
    		                                                                          
      inflows (outflows) from foreign exchange contracts that hedge our net u.k. investment
    		     -1,489,000 8,319,000       63,825,000 20,710,000   -7,223,000 -14,264,000    51,691,000   40,468,000 12,895,000                                                
      effect of exchange rate changes on cash and cash equivalents
    		                               162,000 547,000 653,000 285,000 473,000 -841,000 -1,502,000 -920,000 -1,013,000 -889,000 -653,000                                 
      gains on sale of assets and businesses
    		    -1,399,000                                                                      
      medicare accelerated payments and deferred cares act and other grants
    		       1,214,000 -977,000 2,605,000 136,000 -530,000 -2,418,000 5,089,000 250,000 -1,369,000 -382,000 -187,563,000 -509,448,000 -179,712,000                                                       
      sale of ownership interests to minority members
    		    3,934,000                                                                      
      gain on sale of assets and businesses
    		      -3,725,000                  -5,982,000 0 0  0 -1,810,000 -703,000                                            
      purchase of ownership interests from minority members
    		      -156,000                                                                    
      costs incurred for purchase and implementation of information technology applications
    		                 -671,000 -575,000 2,443,000 -924,000 -2,564,000 -1,857,000 -3,178,000 -4,347,000 -4,215,000 -9,678,000 -10,756,000 -1,400,000                                              
      decrease (increase) in capital reserves of commercial insurance subsidiary
    		                           0 0 0 100,000                                            
      (gain) loss on sale of assets and businesses
    		        0 -5,955,000 -295,000  -500,000    0                                                          
      purchase (sale) of ownership interests by (from) minority members
    		        1,000    -47,782,000 0 -1,307,000                                                            
      sale of ownership interests from minority members
    		          0                                                                
      investment in, and advances to, joint ventures and other
    		                  -129,000  -712,000 466,000 -751,000  0 -11,070,000 -879,000                                                
      inflows from foreign exchange contracts that hedge our net u.k. investment
    		                    -34,576,000                                                      
      costs incurred for purchase of information technology applications, net of refunds
    		                                                                          
      loss on sale of assets and businesses
    		              1,084,000                                                            
      purchase of ownership interests by minority member
    		                                                                          
      purchase of ownership interests by (from) minority members
    		                                                                          
      reduction of long-term debt
    		                 -26,955,000 -251,830,000 211,023,000 -714,258,000 -274,234,000 -185,098,000 11,033,000 -39,558,000 85,923,000 -114,540,000 -730,527,000 -17,499,000 58,206,000 -140,676,000 420,000 -97,851,000 214,958,000 -260,633,000 355,788,000 28,380,000 -676,680,000 -166,671,000 139,205,000 48,287,000 -36,586,000 -109,054,000 -205,993,000 -38,135,000 -126,170,000 -69,926,000 -113,978,000 -66,973,000 -1,197,486,000 -116,626,000 -9,611,000 -68,363,000 -25,556,000 -51,800,000 -109,584,000      -980,000 -101,938,000 -38,886,000  -86,491,000 -176,799,000 -77,069,000 -23,713,000  -56,425   -106,309,105 
      purchase of ownership interests by minority members
    		                 3,830,000 7,603,000                                                        
      property and equipment additions, net of disposals
    		                  -247,459,000 -184,651,000 -192,046,000 -170,508,000 -184,102,000 -153,848,000 -156,327,000 -154,072,000 -169,848,000 -143,613,000 -151,097,000 -181,211,000 -189,041,000 -138,813,000 -156,241,000 -118,114,000 -144,338,000 -123,776,000 -148,448,000 -120,501,000 -127,214,000 -109,743,000 -98,998,000 -81,789,000 -92,387,000 -78,742,000 -103,807,000 -80,025,000 -95,919,000 -90,278,000 -79,164,000 -61,524,000 -56,110,000 -59,064,000 -62,576,000 -105,029,000 -78,219,000 -83,818,000 -74,311,000 -81,751,000 -78,779,000 -85,238,000 -99,349,000 -80,335,000 -69,470,000 -83,203,000 -62,496,000 -50,927,000 -57,920,000 -177,329,000 -118,018,000 -70,436     
      gain on sales of assets and businesses, net of losses
    		                                              -2,092,000                            
      acquisition of property and businesses
    		                       -8,005,000 0 0 0 -2,448,000 -87,085,000 0 -20,931,000 -3,268,000 0 -1,778,000 -17,832,000 -477,582,000 -108,696,000 -7,982,000 -19,543,000 -350,552,000 -148,603,000  -3,301,000 -11,316,000 0   -20,867,000           -21,964,000 -7,817,000 -73,378,000 -31,404,000             
      investment in, and advances to, joint venture and other
    		                                                                          
      increase in cash and cash equivalents
    		                               8,999,000 -1,022,000 3,472,000 29,227,000 -27,997,000 5,471,000 1,683,000 -6,638,000 21,705,000 -2,941,000 -7,642,000     -6,076,000 2,082,000 4,331,000 19,845,000 -2,708,000 5,472,000 -2,315,000 1,200,000 3,963,000    911,000 1,448,000 -3,724,000 -109,533,000 116,139,000 248,000 -32,591,000 60,559,000 21,063,000    1,557 -5,712 14,666 -5,090,946 
      right-of-use assets obtained in exchange for lease obligations
    		                    9,899,000 8,668,000 29,112,000 19,404,000 5,124,000 3,348,000 355,981,000                                                
      medicare accelerated payments and deferred governmental stimulus grants
    		                                                                          
      gains on sales of assets and businesses, net of losses
    		                                       -2,578,000 -1,037,000 0 -10,134,000 -141,000 -696,000                       -5,411,000 -2,338,000      
      capital contributions from minority members
    		                                                                          
      benefit from intangible asset impairment
    		                                                                          
      excess income tax benefits related to stock-based compensation
    		                               0 0 0 0  1,160,000 24,245,000 11,002,000  798,000  11,750,000                                
      investment in and advances to joint venture
    		                                                                          
      acquisition of noncontrolling interests in majority owned businesses
    		                               0 0   0 0                                      
      investment in, and advances to, joint venture
    		                            149,000 -5,384,000 -8,675,000                                            
      costs incurred for purchase and implementation of information technology application
    		                              -8,570,000  -6,953,000 -9,992,000 -9,456,000                                        
      proceeds received from sale/leaseback of real property
    		                                   0 0 0 0 0 0                                  
      cash and cash equivalents, beginning of period
    		                               0 0 0 33,747,000 0 0 0 61,228,000 0 0 0 17,238,000 0 0 0 23,471,000 0 0 0 0 0 9,180,000 0 5,460,000 0 0 16,354,000 0 0 14,939,000 0 0 7,963,000 0 0 33,125,000    0 0 17,750 22,825,152 
      cash and cash equivalents, end of period
    		                               8,999,000 -1,022,000 3,472,000 62,974,000 -27,997,000 5,471,000 1,683,000 54,590,000 21,705,000 -2,941,000 -7,642,000 16,261,000 5,116,000 -436,000 -4,837,000 17,395,000 2,082,000 4,331,000 19,845,000 -2,708,000 5,472,000 6,865,000 1,200,000 9,423,000 1,594,000 -2,705,000 8,916,000 911,000 1,448,000 11,215,000 -109,533,000 116,139,000 8,211,000 -32,591,000 60,559,000 54,188,000    1,557 -5,712 32,416 17,734,206 
      excess income tax benefits related to stock based compensation
    		                                                                          
      interest paid, including early redemption premium and original issue discount write-off in 2014
    		                                       27,188,000  31,609,000                                 
      proceeds received from sale of assets and businesses
    		                                        2,744,000  11,450,000  3,110,000 27,351,000 6,657,000  21,641,000                          
      additional borrowings and related funds
    		                                    3,761,000                                      
      costs incurred for purchase and implementation of electronic health records application
    		                                       0 0 -2,284,000 -6,504,000 -7,458,000 -8,957,000 -16,984,000 -16,412,000 -10,375,000 -16,458,000                          
      increase in insurance subsidiary investments
    		                                                                          
      write-off of deferred financing costs related to extinguishment of debt
    		                                                                          
      return of deposit on terminated purchase agreement
    		                                           0 0 0 0                            
      supplemental disclosures of noncash investing and financing activities:
    		                                                                          
      see notes 2, 4 and 7
    		                                                                          
      cash paid/reserved related to acquisition of property and businesses
    		                                                                          
      decrease in cash and cash equivalents
    		                                          -977,000  -436,000           1,594,000 -2,705,000 -7,438,000                 
      stock based compensation expense
    		                                                                          
      proceeds from sale of noncontrolling interests in majority owned business
    		                                                                          
      (gain) loss on sale of assets
    		                                                                          
      construction management and other receivable
    		                                                  0   3,526,000 17,477,000                    
      capital contributions from noncontrolling interests
    		                                                                          
      purchase of noncontrolling interests in majority owned businesses
    		                                                                          
      gain on sale of assets
    		                                                          0 0 -2,200,000              
      restricted cash related to bond issuance held in escrow pending completion of psi acquisition
    		                                                                          
      proceeds from sale of noncontrolling interest in majority owned business
    		                                                0  300,000                        
      net gain on sale of assets
    		                                                  0                        
      benefit from settlements
    		                                                                          
      settlement proceeds received related to prior year acquisition, net of expenses
    		                                                       0                   
      investment in joint-venture
    		                                                       825,000                   
      proceeds received from sale of assets
    		                                                  16,460,000                        
      acquisition of property and business
    		                                                  0                        
      gains on sale of asset
    		                                                    -1,848,000                      
      proceeds received from sale of asset
    		                                                    2,894,000                      
      net income attributable to uhs
    		                                                     80,893,000 67,541,000                    
      minority interest in earnings of consolidated entities
    		                                                     9,081,000 14,239,000                    
      settlement proceeds received related to prior year acquisitions, net of expenses
    		                                                                          
      capital contributions from minority member
    		                                                       199,000   3,858,000 5,931,000 2,340,000 3,300,000        0     
      minority interest in earnings of consolidated entities, net of distributions
    		                                                       1,902,000 401,000 12,906,000 -219,000 -1,712,000 10,972,000 4,489,000   -7,445,000 7,375,000 5,293,000 13,033,000 11,742,000 5,279 -3,005 4,027 3,581  
      proceeds received from sales of assets
    		                                                          0 0 5,268,000              
      acquisition of assets and businesses
    		                                                               -11,735,000           
      purchase of minority ownership interest in majority owned business
    		                                                          0 0 -14,762,000              
      additional borrowings, net of financing costs
    		                                                       0              19,637    39,271,689 
      construction management receivable
    		                                                                          
      accretion of discount on convertible debentures
    		                                                             0 2,791,000 3,573,000 3,500,000 2,816,000 3,428,000 9,355,000 5,997,000 3,291 3,224 2,505 3,159 10,894,486 
      hurricane insurance recoveries
    		                                                              -25,000,000 -22,291,000           
      hurricane related expenses
    		                                                                          
      hurricane insurance recoveries received
    		                                                             91,571,000 25,000,000 28,000,000           
      net cash received for termination of derivatives
    		                                                             0             
      net provided by financing activities
    		                                                            79,521,000              
      hurricane insurance recoveries, net of proceeds received for operating expenses
    		                                                                          
      gains on sales of assets and businesses
    		                                                                  -9,095,000        
      minority interests in earnings of consolidated entities, net of distributions
    		                                                               10,343,000           
      financing costs on new revolving credit facility
    		                                                                0 -36,000 -1,179,000        
      gains on sales of assets and businesses, net of accrued income taxes
    		                                                                0          
      accrued and deferred income taxes, excluding income taxes on gains on sales of assets and businesses
    		                                                                3,163,000          
      acquisition of businesses
    		                                                                -24,410,000 0 -5,225,000 -147,316,000 -142,391,000  -2,814 0 -45,482  
      repayment of long-term debt
    		                                                                          
      property write-down due to hurricane damage
    		                                                                   2,318,000       
      increase in cash
    		                                                                   -309,000 1,472,000 3,518     
      cash, beginning of period
    		                                                                   34,863,000 34,863,000 34,863     
      cash, end of period
    		                                                                   34,554,000 36,335,000 38,381     
      gross inpatient revenues
    		                                                                   1,684,877,000 1,687,108,000 1,811,781     
      gross outpatient revenues
    		                                                                   663,771,000 649,442,000 649,675     
      total net revenues
    		                                                                   760,314,000 751,598,000 781,366     
      income/(loss) before income taxes
    		                                                                   67,200,000       
      total assets as of 9/30/04
    		                                                                   2,056,140,000       
      licensed beds
    		                                                                   6,225,000 6,314,000 6,528     
      available beds
    		                                                                   5,329,000 5,363,000 5,577     
      patient days
    		                                                                   320,005,000 320,285,000 352,064     
      admissions
    		                                                                   68,827,000 68,831,000 73,413     
      average length of stay
    		                                                                   4,600 4,700 4.8     
      operating income/
    		                                                                    115,366,000      
      total assets as of 6/30/04
    		                                                                    2,051,465,000      
      acquisition of business
    		                                                                     -37,665     
      operating income
    		                                                                     112,479     
      total assets as of 3/31/04
    		                                                                     2,106,923     
      issuance of common stock, net of issuance costs
    		                                                                      1,239 431 525  
      proceeds received from divestitures
    		                                                                       1,200 2,978  
      gains on foreign exchange and derivative transactions
    		                                                                        -6  
      depreciation and amortization
    		                                                                          
      losses on foreign exchange, derivative transactions & debt extinguishment
    		                                                                          
      benefit from insurance settlements and other non-cash charges
    		                                                                          
      changes in assets and liabilities, net of effect from acquisitions and dispositions:
    		                                                                          
      increase in working capital at acquired facilities
    		                                                                          
      proceeds received from merger, sale or disposition of assets
    		                                                                          
      investment in business
    		                                                                          
      net cash paid related to termination of interest rate swap, foreign currency and early extinguishment of debt
    		                                                                          
      losses on foreign exchange and derivative transactions
    		                                                                          
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.